NMRD Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 13:27):

Stats
Today's Volume	10 781.00
Average Volume	38 588.00
Market Cap	1.57M
EPS	$-0.0700 ( 2024-02-23 )
Next earnings date	( $-0.110 ) 2024-07-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.140
ATR14	$0.00600 (11.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-05	Ghadar-ghadr Arash	Buy	100 000	Common Stock
2022-01-05	Ghadar-ghadr Arash	Buy	0
2022-01-28	Natha Salim	Buy	8 000	Stock Option (right to buy)
2022-01-28	Moore Thomas Peter	Buy	8 000	Stock Option (right to buy)
2022-01-31	Mclarney Justin James	Buy	22 293	Common Stock

INSIDER POWER
100.00
Last 26 transactions
Buy: 137 623 617 \| Sell: 137 373 875

Nemaura Medical Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nemaura Medical Inc Financials

Annual	2023
Revenue:	$77 044.00
Gross Profit:	$-1.48M (-1 916.30 %)
EPS:	$-1.010

FY	2023
Revenue:	$77 044.00
Gross Profit:	$-1.48M (-1 916.30 %)
EPS:	$-1.010

FY	2022
Revenue:	$503 906
Gross Profit:	$159 606 (31.67 %)
EPS:	$-0.590

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.280

Financial Reports:

No articles found.

Nemaura Medical Inc

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.